| Parameter | Number (N = 100) |
| Mean age (SD) year | 52 |
| Female sex | 69 |
| Performance statuts 0 - 1 2 3 - 4 |
73 27 0 |
| Treatment facility Outpatient Inpatient |
97 3 |
| Primary site Solid tumors Breast cancer Gastrointestinal cancer Head and neck cancers Gynecological cancers Lung cancer Urogenital cancers Brain cancer Skin cancer Sarcoma |
39 22 11 10 10 4 2 2
|
| Stage Nonmetastatic Metastatic Single site Multiple site |
60 40 77 33 |
| Evidence of disease activity Treatment IV chemotherapy Radiotherapy (RT) RT alone RT with chemosensitizers (e.g., 5-FU with RT in rectal cancer, with cisplatine VADS cancers) Oral Chemotherapy/hormonotherapy (e.g., tamoxifen and busulfan) |
75 0 10
25
27 |
| Route Oral Parenteral Comorbid diseases |
30 75 27 |